Peijia Medical-B (9996.HK): Dual-wheel drive performance of valvular intervention and neurological intervention continues to grow at a high level
中信建投證券Oct 13, 2023 18:22
Peijia Medical-B (9996.HK): Valve and Shinsuke Two-wheel Drive Innovation Empowers Growth
國泰君安Oct 7, 2023 09:02
Peijia Medical-B (09996.HK): Major R&D progress in the first half of the year was in line with expectations
中金公司Sep 5, 2023 14:22
Peijia Medical-B (09996.HK): 23H1 performance is impressive, valves/nerve pipelines continue to gain strength
廣發證券Sep 4, 2023 12:32
Peijia Medical-B (9996.HK): TAVR/Neural Intervention Dual Wheel Drive Operation Efficiency Optimization
華泰證券Sep 1, 2023 16:12
Peijia Medical-B (9996.HK): TAVR Braves New Advanced Neurological Interventions Flourish
華泰證券Jul 25, 2023 07:26
Peijia Medical-B (09996.HK): Outstanding 23H1 operating data and rapid revenue growth
廣發證券Jul 24, 2023 14:22
Peijia Medical-B (09996.HK): TAVR's market share continues to expand and accelerate sales of Shensuke products
華安證券Jul 21, 2023 00:00
Peijia Medical-B (9996.HK): TAVR innovates new advanced neurological intervention products
華泰證券Apr 3, 2023 00:00
Peijia Healthcare (9996.HK): Interventional Device Incubation Platform Unveiled on 2023 R&D Day to Show Depth of Pipeline Layout
浦銀國際Mar 6, 2023 00:00
Peijia Medical-B (09996.HK): Research pipeline progressed smoothly, TAVR implants recovered strongly
中金公司Mar 4, 2023 00:00
Peijia Healthcare (9996.HK): Adjust 2022-24E profit forecast and maintain target prices
浦銀國際Jan 30, 2023 00:00
Peijia Medical-B (9996.HK): Revenue continues to grow rapidly under the influence of the epidemic and is optimistic about the company's long-term development
中信建投證券Jan 20, 2023 00:00
Peijia Medical-B (09996.HK): The performance forecast is basically in line with expectations for accelerated growth in 2023
中金公司Jan 19, 2023 07:51
Peijia Medical-B (09996.HK): 1H22 is in line with expectations for strong dual-engine growth
中金公司Sep 2, 2022 00:00
Peijia Medical-B (09996.HK): TAVR+ neuro-interventional two-wheel drive pipelines enrich the space for long-term growth
東吳證券Aug 24, 2022 00:00
Peijia Healthcare (09996.HK): TAVR achieves rapid volume release
興業證券Aug 23, 2022 16:21
Peijia Medical-B (9996.HK) Interim Report Review: TAVR Increases Eye Brightening Nerve Interventions Continue to Promote Innovation
華泰證券Aug 23, 2022 14:46
Peijia Medical-B (09996.HK) 2022 semi-annual report review: TAVR released rapidly, neurological intervention business grew rapidly
華創證券Aug 22, 2022 18:06
Peijia Medical-B (09996.HK): Leading Heart Valve Companies Fully Deploy Neural Interventions
中金公司Jul 1, 2022 18:06
No Data
No Data